ASX Sector Performance: Top Performers of 2024 – Stocks to Watch and Consider

This year, the ASX has delivered a fascinating mix of sector performances, reflecting the broader economic and market trends. Topping the list is the Information Technology sector, which surged by more than 55% thanks to strong demand for digital solutions like cloud computing and cybersecurity. Following closely, the Financials sector grew by more than 34% as banks benefited from rising credit demand and a strengthening economy. The A-REITs sector posted a growth rate of +21%, supported by a real estate market recovery and attractive dividend yields in a low-interest-rate environment. The Consumer Discretionary sector also grew by more than 21%, as recovering consumer confidence brought renewed energy to retail and entertainment. Finally, the Health Care sector recorded nearly 8% growth, driven by an aging population and advances in medical technology. These results tell an intriguing story about the ASX in 2024. The dominance of Information Technology underscores the ongoing impact of digital transformation across industries, while the strong performance of Financials, A-REITs, and Consumer Discretionary sectors highlights a broader recovery in spending, credit, and property markets. Health Care remains a reliable growth driver. Together, these trends demonstrate the ASX’s resilience and adaptability as it navigates shifting economic landscapes and looks ahead to 2025. Let’s explore five standout stocks from each sector that are outperforming the market and poised for further growth. Technology: NUIX Ltd (ASX: NXL) – Up +241% year-to-date Nuix Ltd (ASX: NXL) is shaping up to be a strong investment opportunity, supported by solid financial results. For FY24, the company saw a 20.9% increase in revenue, reaching $220.6 million, and a 14% rise in annualized contract value (ACV), totalling $211.5 million. We were especially impressed by a 60.2% jump in operating profit (EBITDA) to $55.9 million and a major turnaround in net income, which hit $5 million. These results highlight Nuix’s ability to drive growth and take advantage of increasing demand in its market. Looking forward, we see Nuix targeting a 15% increase in ACV for FY25, with revenue growth expected to outpace operating costs. The launch of Nuix Neo, which has already shown strong sales growth, is likely to be a big contributor. Each Nuix Neo sale is expected to be two to three times larger than traditional sales, pointing to strong demand and the potential for significant revenue growth. Nuix is also well-positioned with strategic partnerships, like its collaboration with Veritone for AI integration, strengthening its foothold in the growing investigative analytics and intelligence software space. Given its strong financial performance, positive growth outlook, and strategic market positioning, we believe Nuix Ltd is an appealing investment. With solid fundamentals and strong growth potential, it offers a great opportunity for investors looking to tap into the expanding analytics and intelligence software market. Technically, the recent pullback to the $6 - $6.55 range presents an opportunity for a long-term buy, which corresponds to the 23.6% Fibonacci retracement level from the July 2023 lows to the recent November highs. Financial: Zip Co Ltd (ASX: ZIP) – Up +443% year-to-date We see Zip Co Ltd (ASX: ZIP) as a promising long-term buy, and here’s why. Zip has posted some impressive financial results that show strong growth potential. For instance, its revenue surged by 75.7% year-on-year, reaching $868 million in FY24. This growth highlights the rising demand for its buy-now-pay-later (BNPL) services, which continue to attract consumers looking for flexible payment options. Additionally, Zip has turned things around financially, moving from significant losses to a net profit of $6 million, showcasing its improving operations and potential for sustained profitability. The company’s cash flow is another strong point. With a free cash flow margin of 34%, Zip is generating solid cash relative to its sales. This healthy cash flow allows the company to reinvest in its business and fund its future growth, which is a positive sign for long-term investors. We’re also impressed by Zip’s strategic global expansion. The acquisition of Quadpay and its move into the U.S. market have helped position it as a key player in the competitive BNPL space. With its diverse range of offerings, ranging from point-of-sale credit to digital payment solutions, Zip is strengthening its market presence. Overall, Zip Co Ltd offers a solid investment case with strong financials, a healthy cash flow, and a strategic market position. For those looking to invest in the growing BNPL sector, Zip presents an attractive long-term opportunity. How to ‘buy’ and when to ‘buy’ ZIP shares? Technically, since June, ZIP shares have gained about 227%, and we may expect a near-term pullback, which could eventually present an interesting risk-adjusted entry. Based on the Fibonacci retracement from the June lows to recent highs, we see potential for a price retracement back to the $2.30 - $2.50 per share range, which corresponds to the intrinsic value according to our analysis, which blends a 5-year discounted cash flow model and multiples-based relative valuation. This range could offer an interesting risk-adjusted entry. Therefore, we suggest employing a dollar-cost averaging method with periodic entries between the current market price and $2.30 per share. Real Estate: Goodman Group (ASX: GMG) – Up +53% year-to-date We have been covering Goodman Group (ASX: GMG) since its shares were priced at $14.37 each. Currently, GMG is trading at approximately $38 per share, representing more than a two-fold increase in its valuation since our initial recommendation. Goodman Group (ASX: GMG) is shaping up to be an excellent long-term investment, offering both strong growth potential and a reliable dividend, making it an attractive choice for investors seeking a balance of capital appreciation and steady income. The company has shown solid financial performance, with earnings expected to grow by 9% per share for FY 2025. This positive outlook is driven by Goodman’s strategic investments in high-demand sectors like logistics and data centres. As the world increasingly turns to e-commerce and the need for secure data storage grows, Goodman’s portfolio positions it well to capitalize on these trends, ensuring strong revenue streams moving forward. What makes Goodman particularly appealing is its well-diversified portfolio. The company has built a global property business with a focus on logistics, warehouses, and data centres, sectors with strong growth drivers. Goodman’s focus on data centres, in particular, places it in a rapidly expanding market, positioning the company for significant future revenue growth. In addition to its growth prospects, Goodman provides a consistent dividend, offering investors reliable income alongside the potential for capital appreciation. This steady payout adds another layer of appeal for those looking for both growth and income from their investments. Overall, Goodman Group combines solid earnings growth, a strategic position in high-demand markets, and a reliable dividend, making it a compelling option for long-term investors who want both stability and growth in the real estate sector. Consumer Discretionary: Supply Network Ltd (ASX: SNL) – Up +93% year-to-date We see Supply Network Ltd (ASX: SNL) as a strong long-term investment, and there are a few key reasons why. In FY24, the company posted impressive results, with revenue growing by 20% to $302.6 million, and profit before tax up 18%. This shows that demand for its aftermarket parts is solid, and the company is in a good position to keep growing. We’re also impressed by how well Supply Network has managed its operations, with profit margins improving in the second half of the year, which bodes well for its ability to stay profitable as it expands. One of the things that stands out to us is the company’s Return on Capital Employed (ROCE) of 34%, far higher than the industry average. This indicates that Supply Network is making smart decisions with its capital and generating strong returns for shareholders. Looking ahead, we’re confident in its growth potential, especially with an expected annual market expansion of 5% to 10% over the next decade. The company’s expansion plans, including a new site in Perth and upgrades to its Melbourne distribution centre, should help it handle growing demand and continue to scale. On top of the growth potential, we also see Supply Network as a solid pick for members who are looking for steady income. The company has a solid dividend payout ratio of 71.23%, with a yield of around 1.71%. With its strong financials, high ROCE, and promising outlook, we think Supply Network is a great long-term investment, especially for those interested in the aftermarket parts sector. How to “buy” and when to “buy” SNL? Technically, SNL has recently broken its key resistance level at $32 per share, opening the door for a rally potentially up to $40 per share. However, we remain cautious of a possible false breakout. Therefore, we suggest members deploy capital using a dollar-cost averaging method to improve the risk-adjusted entry price. Based on our analysis, we have concluded an intrinsic value of $22.35 per share, derived from a combined valuation using a 5Y discounted cash flow model, a dividend multi-stage discount model, and a multiples relative valuation method. The fair value lies in the range corresponding to the Fibonacci retracement levels of 38.2% and 50% from the October 2023 lows to recent highs. That said, we are considering the risk of a pullback to this price range before consolidating for a rally above $40 per share. Healthcare: Sigma Healthcare Ltd (ASX: SIG) – Up +190% year-to-date Sigma Healthcare Ltd (ASX: SIG) is shaping up to be an attractive long-term investment, especially with its proposed merger with Chemist Warehouse. We see this merger as a major opportunity to consolidate the Australian pharmaceutical sector, creating a more efficient and powerful entity. With the Australian Competition and Consumer Commission (ACCC) approving the deal, we are confident that the merger has strong regulatory support, which should help Sigma move forward smoothly. From a fundamental standpoint, Sigma is in a strong position. The company operates Australia’s largest pharmacy network and has key contracts within the Pharmaceutical Benefits Scheme (PBS), ensuring a steady revenue stream. With the healthcare sector continuing to grow, the merger should further enhance Sigma’s market presence and provide a platform for long-term growth. That said, we believe members should remain mindful of potential risks. Regulatory scrutiny will continue to be a factor, and the recent surge in Sigma’s share price could lead to short-term volatility as some profit-taking occurs. Despite this, we view Sigma’s strong infrastructure and growth potential as reasons to be optimistic about its long-term prospects in the evolving Australian healthcare market.